India is set to launch low-cost generic versions of popular weight-loss injections like Ozempic following patent expirations. This move promises to significantly expand access to these treatments, previously considered a luxury, especially in middle-income countries. Doctors anticipate a surge in patients as prices are expected to drop dramatically.